跳至主要内容
临床试验/NL-OMON39556
NL-OMON39556已完成3 期

Randomized Controlled Trial Investigating the Efficacy and Safety of Nebulized Heparin versus Placebo in Burn Patients with Inhalation Trauma - The Hepburn*study

Academisch Medisch Centrum0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - informed consent
  • - age > 18 years
  • - need for intubation and mechanical ventilation
  • - clinical diagnosis of inhalation trauma confirmed by bronchoscopy

排除标准

  • - > 36 hours after trauma
  • - Receiving invasive ventilation > 24 hours
  • - Expected duration of mechanical ventilation < 24 hours
  • - Chronic obstructive pulmonary disease GOLD stage III and IV
  • - Any history of pulmonary hemorrhage in the past 3 months
  • - Any history of significant bleeding disorder
  • - Known allergy to heparin, including heparin*induced thrombocytopenia
  • - Pregnancy or breast feeding
  • - Unlikely to survive for > 72 hours
  • - Total body surface area (TBSA) > 60%
  • - Witnessed or proven aspiration (i.e., confirmed by bronchoscopy)

研究者

相似试验